U.s. Global Investors (GROW) has disclosed a new risk, in the Regulation category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The enactment of the GENIUS Act in July 2025 presents a potential risk for U.S. Global Investors, as it introduces a stringent regulatory framework for payment stablecoin issuers. Although U.S. Global Investors’ operations remain unaffected directly, the companies they invest in might face increased operational costs and compliance challenges due to new licensing, reserve segregation, and audit requirements. Such regulatory burdens could hinder growth and introduce compliance risks, potentially diminishing the value of U.S. Global Investors’ investments and impacting their financial performance. This underscores the importance of monitoring regulatory changes and assessing their implications on investment strategies.
The average GROW stock price target is $2.50, implying 4.17% upside potential.
To learn more about U.s. Global Investors’ risk factors, click here.